Risk of Osteoarthritis in an Incident Cohort of People With Psoriatic Arthritis: A Population-based Cohort Study
暂无分享,去创建一个
G. Shaddick | W. Tillett | R. Charlton | N. McHugh | Catherine H. Smith | A. Nightingale | J. Snowball | A. Green
[1] C. Coupland,et al. Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD). , 2020, Osteoarthritis and cartilage.
[2] A. Ogdie,et al. Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States , 2020, BMC Rheumatology.
[3] P. Dagnelie,et al. Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink. , 2019, Diabetes research and clinical practice.
[4] A. Silman,et al. Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink , 2018, Pharmacoepidemiology and drug safety.
[5] G. Shaddick,et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study , 2018, Rheumatology.
[6] G. Shaddick,et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis , 2018, The British journal of dermatology.
[7] G. Shaddick,et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort , 2017, Rheumatology.
[8] Gavin Shaddick,et al. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study , 2017, Annals of the rheumatic diseases.
[9] F. Blyth,et al. Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992–2013 , 2017, Rheumatology.
[10] Matthew L. Thomas,et al. Effect of anti‐TNF and conventional synthetic disease‐modifying anti‐rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis , 2016, Rheumatology.
[11] A. Ogdie,et al. The Epidemiology of Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.
[12] K. Jordan,et al. Annual consultation incidence of osteoarthritis estimated from population-based health care data in England , 2015, Rheumatology.
[13] K. Bhaskaran,et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.
[14] A. Ogdie,et al. Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network , 2014, Pharmacoepidemiology and drug safety.
[15] C. Cooper,et al. Epidemiology and burden of osteoarthritis. , 2013, British medical bulletin.
[16] D. Margolis,et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis , 2011, The British journal of dermatology.
[17] J. Jordan,et al. Epidemiology of osteoarthritis. , 2010, Clinics in geriatric medicine.
[18] C. Cavill,et al. A modified sharp score demonstrates disease progression in established psoriatic arthritis , 2010, Arthritis care & research.
[19] M. Dougados,et al. Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study). , 2009, Joint, bone, spine : revue du rhumatisme.
[20] S. Bierma-Zeinstra,et al. Osteoarthritis , 2006, The Lancet.
[21] D. Gladman,et al. Psoriatic Arthritis. , 2017, The New England journal of medicine.
[22] A. Tan,et al. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. , 2015, Rheumatology.
[23] W. Eyler,et al. PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.